SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-006141
Filing Date
2024-04-29
Accepted
2024-04-29 17:00:31
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cycc-20231231x10ka.htm   iXBRL 10-K/A 559854
2 EX-31.1 cycc-20231231xex31d1.htm EX-31.1 13321
3 EX-31.2 cycc-20231231xex31d2.htm EX-31.2 13045
  Complete submission text file 0001558370-24-006141.txt   894323

Data Files

Seq Description Document Type Size
4 EX-101.SCH cycc-20231231.xsd EX-101.SCH 4506
5 EX-101.DEF cycc-20231231_def.xml EX-101.DEF 46101
6 EX-101.LAB cycc-20231231_lab.xml EX-101.LAB 23856
7 EX-101.PRE cycc-20231231_pre.xml EX-101.PRE 21466
20 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20231231x10ka_htm.xml XML 11224
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50626 | Film No.: 24892285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)